| Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer L Tam, LM McGlynn, P Traynor, R Mukherjee, JMS Bartlett, J Edwards British journal of cancer 97 (3), 378-383, 2007 | 206 | 2007 |
| Is PTEN loss associated with clinical outcome measures in human prostate cancer? P McCall, CJ Witton, S Grimsley, KV Nielsen, J Edwards British journal of cancer 99 (8), 1296-1301, 2008 | 178 | 2008 |
| The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer J Edwards, P Traynor, AF Munro, CF Pirret, B Dunne, JMS Bartlett Clinical Cancer Research 12 (1), 123-130, 2006 | 127 | 2006 |
| Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma SM Denley, NB Jamieson, P McCall, KA Oien, JP Morton, CR Carter, ... Journal of gastrointestinal surgery 17 (5), 887-898, 2013 | 110 | 2013 |
| Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients P McCall, LK Gemmell, R Mukherjee, JMS Bartlett, J Edwards British journal of cancer 98 (6), 1094-1101, 2008 | 110 | 2008 |
| Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer R Mukherjee, DH McGuinness, P McCall, MA Underwood, M Seywright, ... British journal of cancer 104 (12), 1920-1928, 2011 | 105 | 2011 |
| NFêB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression P McCall, L Bennett, I Ahmad, LM Mackenzie, IWG Forbes, HY Leung, ... British journal of cancer 107 (9), 1554-1563, 2012 | 75 | 2012 |
| Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients JM Willder, SJ Heng, P McCall, CE Adams, C Tannahill, G Fyffe, ... British journal of cancer 108 (1), 139-148, 2013 | 67 | 2013 |
| High IKKá expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)‐positive breast cancer L Bennett, J Quinn, P McCall, EA Mallon, PG Horgan, DC McMillan, ... International journal of cancer 140 (7), 1633-1644, 2017 | 35 | 2017 |
| Nuclear factor êB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor L MacKenzie, P McCall, S Hatziieremia, J Catlow, C Adams, P McArdle, ... Human pathology 43 (9), 1491-1500, 2012 | 20 | 2012 |
| An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients P Traynor, LM McGlynn, R Mukhergee, SJS Grimsley, J Bartlett, ... Disease markers 24 (3), 157-165, 2008 | 20 | 2008 |
| Bad expression influences time to androgen escape in prostate cancer K Teo, L Gemmell, R Mukherjee, P Traynor, J Edwards BJU international 100 (3), 691-696, 2007 | 20 | 2007 |
| Androgen receptor phosphorylation at serine 308 and serine 791 predicts enhanced survival in castrate resistant prostate cancer patients P McCall, CE Adams, JM Willder, L Bennett, T Qayyum, C Orange, ... International journal of molecular sciences 14 (8), 16656-16671, 2013 | 19 | 2013 |
| Tumoral C-reactive protein and nuclear factor kappa-B expression are associated with clinical outcome in patients with prostate cancer P McCall, J Catlow, PA McArdle, DC McMillan, J Edwards Cancer Biomarkers 10 (2), 91-99, 2012 | 17 | 2012 |
| Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence S Hatziieremia, Z Mohammed, P McCall, JM Willder, AK Roseweir, ... Molecular carcinogenesis 55 (11), 1667-1677, 2016 | 16 | 2016 |
| Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer MJ McAllister, P McCall, A Dickson, MA Underwood, D Andersen, ... Prostate Cancer and Prostatic Diseases 23 (4), 596-606, 2020 | 10 | 2020 |
| Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer AK Roseweir, P McCall, A Scott, B Liew, Z Lim, EA Mallon, J Edwards Oncotarget 8 (23), 37172, 2017 | 8 | 2017 |
| Determining the prognostic significance of IKKá in prostate cancer M Montes, L MacKenzie, MJ McAllister, A Roseweir, P McCall, ... The Prostate 80 (14), 1188-1202, 2020 | 7 | 2020 |
| The relationship between androgen receptor, components of tumour microenvironment and survival in breast cancer molecular subtypes F Gujam, K Dickson, P McCall, D McMillan, J Edwards Cancer Therapy and Oncology 11 (3), 2018 | 4 | 2018 |
| The interaction between the PI3K/Akt cascade and the androgen receptor in the development and progression of castrate resistant prostate cancer P McCall University of Glasgow, 2011 | 2 | 2011 |
